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Evaluating the risk for central nervous system (CNS)
effects after whole-body or partial-body irradiation presents
challenges due in part to the varied exposure scenarios in the
context of occupational, accidental or wartime releases. Risk
estimations are further complicated by the fact that robust
changes in brain function are unlikely to manifest until
significantly late post exposure times. Collectively, the
current data regarding CNS radiation risk are conflicting
in humans and a survey of the animal model data shows that
it is similarly inconsistent. Due to the sparseness of such data,
the current study was conducted using male and female mice
to evaluate the brain for the delayed effects of a 2 Gy whole-
body exposure to c rays starting six months postirradiation.
Behavioral testing indicated sex-specific differences in the
induction of anxiety-like behaviors and in the ability to
abolish fear memories. Molecular analyses showed alter-
ations in post-synaptic protein levels that might affect
synaptic plasticity and increased levels of global DNA
methylation, suggesting a potential epigenetic mechanism
that might contribute to radiation-induced cognitive dys-
function. These data add to the understanding of the CNS
response to whole-body irradiation and may lead to improved
risk assessment and provide guidance in the development of
effective radiation countermeasures to protect military
personnel and civilians alike.  2020 by Radiation Research Society
INTRODUCTION
The age of the atomic bomb ushered in many changes for
humankind, and certain concerns regarding the potential
risks of adverse health effects after exposure to ionizing
radiation persist to this day. Since the advent of the splitting,
then fusing, of atomic nuclei, we have learned to capitalize
on the ionizing properties of select radiation types for
energy production, industrial applications and medical
diagnostics and therapeutics. Unfortunately, many of these
benefits come at a cost, exemplified by accidental industrial
releases such as that experienced at Fukushima Daiichi in
2011 or through the realistic threats of a terrorist-mediated
radiologic attack. Whether accidental or intentional, estab-
lishing the health risks associated with radiation exposures
is extremely complicated, and confounded by a variety of
biological and sex-specific factors that affect radiosensitiv-
ity, as well as dosimetry, and the difficulties of accounting
for differences in radiation quality, dose rate and absorbed
dose-depth profiles in an exposed population (1–4). The
varied exposure scenarios that include whole- or partial-
body irradiation in the context of occupational, accidental or
wartime releases, or cranial irradiation in the context of
medical procedures, underscore the complexities of risk
estimation.
It has been well documented that clinically relevant
radiotherapy paradigms used in the treatment of glioma and
secondary malignancies of the brain induce persistent and
progressive cognitive impairments that manifest long after
the cessation of treatment (5–7). These clinical fractionated
irradiation paradigms typically employ relatively high doses
(;60 Gy) of low-linear energy transfer (LET) X rays or
protons (8), which induce cognitive impairments that
adversely affect quality of life for many cancer survivors.
Similarly, whole-body radiation exposures also raise
concerns for health risks. For many clinical occupations,
including radiologists, radiology technicians and imaging
practitioners, as well as power plant workers and even
airline pilots and flight attendants, it is possible to be
exposed to radiation doses that can affect brain function (9).
However, the majority of humans, though, the greatest risks
of radiation exposure would involve accidental releases or
terrorist-mediated radiological events able to expose large
numbers of military personnel and civilians to a range of
whole- and partial-body exposures. In the event of nuclear
fallout or a dirty bomb blast, radiation types are likely to
include gamma rays, X rays, a- and b particles or neutrons
emitted from nuclear interactions and isotopic decay. It is
well documented that relatively high-dose exposures (6
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Gy) in such scenarios have the potential to induce acute
radiation syndromes that affect the hematopoietic system or
gastrointestinal tract and require immediate medical inter-
vention (10). A less tangible, but problematic outcome of
such exposures may also include an increased lifetime risk
of secondary radiogenic cancers (11). A third, but largely
undefined late-risk of non-lethal exposures is injury to the
central nervous system (CNS) that results in cognitive
impairments. While therapeutic cranial radiation exposures
have consistently been demonstrated to elicit impairments in
learning and memory, and increased anxiety- or depression-
like behaviors (12), lower-dose diagnostic and/or occupa-
tional radiation exposures to the cranium and/or whole body
have led to inconsistent CNS results, largely owing to
differing mammalian model systems, variable behavioral
testing paradigms and inappropriate times of postirradiation
analyses (i.e., too early). These realities have led to a
misconception that CNS deficits only manifest after lethal
irradiation, which is inaccurate.
Evaluating the CNS effects after lower dose whole- and/
or partial-body irradiation scenarios presents challenges, in
particular due to the lack of robust changes that transpire
early after exposure. Possibly for this reason, there is little
information regarding the risk of adverse effects on the
brain after exposures used to simulate an occupational,
deliberate or accidental radiation release. In addition,
because a significant number of first responders, cleanup
workers and civilians could also be at risk, this scenario
takes on even greater importance. If cognitive impairments
manifest at lower doses and progress over time they could
clearly impact an individual’s ability to adapt and respond
in stressful situations. As impairments continue to manifest
or worsen, they present a clear and adverse effect on longer-
term quality of life, including increased risks of developing
mood disorders, learning and memory impairments, as well
as progressive neurodegenerative disease-like symptoms
(13–15). For these reasons adult male and female mice were
used in this study to evaluate the brain for the delayed
effects of a whole-body gamma-ray exposure that would not
induce acute radiation syndromes. Understanding the CNS
response to this radiation exposure scenario will improve
risk assessment and provide guidance in the development of
effective radiation countermeasures to protect military
personnel and civilians alike.
MATERIALS AND METHODS
Animals and Irradiation
All animal experimental procedures were conducted in accordance
with the guidelines provided by the National Institutes of Health and
approved by the University of California Irvine Institutional Animal
Care and Use Committee. Animals were maintained in standard
housing conditions (208C 6 18C; 70% 6 10% humidity; 12:12 h
light-dark schedule) and provided ad libitum access to standard rodent
chow (Teklad 2020x; Envigo RMS Inc. Indianapolis, IN) and water.
Single cohorts of 2-to-2.5-month-old wild-type male mice or female
mice (C57BL/6J; Jackson Laboratory, Bar Harbor, ME) were
randomly assigned to either 2 Gy irradiated (N ¼ 12 females, N ¼
14 males) or sham-irradiated concurrent control (N¼ 12 females, N¼
12 males) experimental groups and acclimated in the vivarium for
approximately two weeks prior to irradiation. Mice were lightly
restrained in a well-ventilated Lucitet irradiator pie cage for whole-
body 2 Gy exposure using a 137Cs gamma-ray irradiator at a dose rate
of 2.07 Gy/min (JL Shepherd & Associates, San Fernando, CA).
Concurrent control mice were placed into the pie cage and irradiator
for the same length of restraint and exposure time as that required to
deliver the 2 Gy dose.
Behavioral Testing
Behavioral studies were initiated at 6–7 months postirradiation
where male mice were tested separately from female mice. For one
week prior to behavioral studies, the lead investigator, blinded to the
animal grouping, handled all mice for habituation. Testing occurred
over a two-week period and included the following paradigms in the
following order: elevated plus maze (EPM), light-dark box (LDB),
forced swim test (FST) and fear extinction (FE). Independent
investigators, blinded to the experimental groups, scored all behavior
videos. These behavioral testing paradigms measure anxiety and
despair, as well as fear learning and memory and fear consolidation,
which involve interplay between cellular circuits of various brain
regions, including frontal cortex, hippocampus and amygdala (16, 17).
The EPM and LDB tests are based on the tendency of anxious
rodents to avoid open or brightly-lit areas and to exhibit reluctance to
explore open environments, resulting in reduced amounts of time
spent in the open arms of the EPM or in reduced numbers of
transitions between the dark and light compartments of the LDB
testing arena (18, 19). The EPM consists of two open arms and two
closed arms arranged such that the two open arms are opposite each
other and at 90 degrees to the closed arms in the shape of a plus sign,
elevated 40 cm off the floor, placed in a brightly-lit (915 lux) room
(18). Each mouse was placed in the neutral center zone of the plus
maze and allowed to explore for 5 min. Anxiety-like behavior was
scored as the percentage time spent in the open arms of the maze
compared to the closed arms. After EPM, on the next day, mice were
tested on LDB, where anxiety was measured by a mouse’s willingness
to transition freely between a large well-lit chamber (303 20327 cm,
915 lux) through a 7.5 3 7.5 cm opening to a smaller, dimly-lit
chamber (15 3 103 27 cm, 4 lux). Fewer transitions during the 10-
min test would suggest increased anxiety-like behavior (19).
Mice were next tested for depression-like or despair-like behavior
using the FST, where the mouse was placed in a beaker of water such
that the mouse could not escape from the beaker, nor touch the bottom
(15 cm diameter3 20 cm, 228C). Each mouse underwent a 5-min test
that was scored for the time climbing or swimming as opposed to the
time immobile or floating where the mouse moved only enough to
keep the nose above water. An increase in the percentage test time
engaged in floating suggested increased despair-like behavior (20).
For all of these tests, N ¼ 12–14 mice/group, as described in the
‘‘Animals and Irradiation’’ section.
The final behavior test administered was the FE test where two
contexts (A and B) were used to determine whether mice could learn
and then extinguish conditioned fear responses (21). The conditioning
test chamber (context A; 17.5317.5318 cm; Coulbourn Instruments,
Holliston, MA) had a steel grid floor and the scent of 10% acetic acid
in water, while the extinction chamber (context B) had a smooth
Plexiglast floor, additional stimulus lighting and the scent of 10%
almond extract in water. Digital cameras were mounted in the ceiling
of each chamber and connected via a quad processor for automated
scoring of freezing (FreezeFrame, Coulbourn Instruments). For each
mouse, the fear conditioning protocol started with a 120-s pre-fear
conditioning incubation followed by three pairings of a 120 s, 80-dB,
16-kHz white noise conditioned stimulus (CS) co-terminating with a 1
s, 0.6-mA foot shock (US), presented at 2-min intervals (day 1, T1–T3).
For extinction, each mouse was exposed to context B where they were
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allowed to acclimate for 2 min, and then, extinction training comprised
15 non-reinforced 120 s CS presentations at 5 s intervals. Fear
extinction data are presented as the average of five tones. Extinction
training was repeated on each of three days. Subsequently, retention
testing was performed on day 5 at which time each mouse was
returned to context B where, after a 2-min acclimation, freezing was
assessed during three non-US reinforced CS tones (16 kHz, 80 dB,
lasting 120 s) at 2-min intervals. Extinction memory was calculated as
the percentage of time spent freezing during the tests. For this test, N¼
8–12 mice/group.
Immunohistochemistry
Immediately after behavior studies were completed, immunohisto-
chemical analyses were performed on a subset of the same mice that
had been used in the behavior studies. Mice were deeply anesthetized
with isoflurane and euthanized via intracardiac perfusion using 4%
paraformaldehyde (Acros Organicse, NJ) in 100 mM phosphate
buffered saline (PBS, pH 7.4; Gibcot, Grand Island, NY). Brains were
cryoprotected (10–30% sucrose gradient) and sectioned coronally into
30 lm using a cryostat (Leica Microsystems, Nussloch, Germany).
For each end point, 3–4 representative coronal brain sections from
each of 3–4 animals per experimental group were selected at
approximately 15 section intervals and stored in Tris-buffered saline
(TBS, 100 mM, pH 7.4, Sigma-Aldricht, St. Louis, MO). For the
immunofluorescence labeling of PSD-95 and microglial activation
marker CD68 mouse anti–PSD-95 (1:1,000; Thermo Scientifice,
Waltham, MA) and rat anti-mouse CD68 (1:500; AbD Serotec,
Raleigh, NC) primary antibodies were used with Alexa Fluort 594
secondary antibody (1:1,000). Tissues were then DAPI nuclear
counterstained and sealed in slow-fade/antifade mounting medium
(Life Technologies, Grand Island, NY). Similarly, for the immuno-
fluorescence of 5mC and 5hmC, mouse monoclonal anti-5mC
(1:2,000; EpiGentek Group Inc., Farmingdale, NY) and rabbit
polyclonal anti-5hmC (1:5,000; Active Motift, Carlsbad, CA) primary
antibodies were used with Alexa Fluor 594 secondary antibody,
respectively, at a dilution of 1:750.
Confocal Microscopy, Image Processing and Three-Dimensional
Quantification
The immunostained brain sections were scanned using a confocal
microscope (Nikon Eclipse Ti C2) equipped with a 403 PlanApo oil-
immersion lens (1.3 NA, Nikont Instruments Inc., Melville, NY) and
a NIS-Elements AR interface version 4.30 (Nikon Instruments). A
total of 30 z stacks (1,024-bit depth) at 0.5 lm from three different
fields (318 3 318 3 24 lm) in each section were imaged from the
dentate gyrus (DG) or from the amygdala. The digitized z stacks were
deconvoluted using AutoQuant software version X3.0.4 (Media
Cybernetics Inc., Rockville, MD). An adaptive, 3D blinded method
was used to create deconvoluted images for direct import into the
Imaris module, version 8.1.2 (Bitplane AG, Zurich, Switzerland). The
3D algorithm-based surface rendering and quantification of fluores-
cence intensity for each fluorescently labeled marker was performed in
Imaris at 100% rendering quality. Each channel was analyzed
separately. The 3D surface rendering detects immunostained puncta
or nuclear staining (DAPI) satisfying pre-defined criteria, for the
puncta size (0.5–1 lm) and verified visually for accuracy. Using
deconvoluted confocal z stack volume from the control group
(nonirradiated) as a baseline for the minimum thresholding, a channel
mean intensity filter was applied and used for all the experimental
groups for each batch of molecular markers. The pre-set parameters
were kept constant throughout the subsequent analysis of immuno-
reactivity for each antigen. To maintain uniformity among the varying
number of puncta for each individual time point and/or antigen
analyzed, the number of puncta per 318 3 318 3 24 lm was
normalized to control and data were expressed as a mean
immunoreactivity (percentage) relative to nonirradiated controls.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism version 6
(LaJolla, CA). Unpaired Student’s t tests were used to determine
significance between control and irradiated groups of mice where P 
0.05 was considered statistically significant. Given that the distribu-
tion of behavior data is gamma distributed, we also applied a non-
parametric approach, kernel density estimation (KDE), to calculate the
proportion of mice that exhibited impaired performance within each
cohort for a given behavior task (22). Analogous to the Z-score
principle, a performance level that encompassed 95% of the
probability density of the control cohort’s performance data was
selected as the threshold level, below which an individual animal’s
performance would be classified as ‘‘severely impaired’’.
RESULTS
Radiation has been shown with some consistency to
induce impairments in learning and memory, and increased
anxiety- or depression-like behaviors after charged particle
or clinically relevant exposures (12, 23). Similarly,
differences in the sensitivity of the CNS to such exposures
have been reported between males and females (4, 24, 25).
Conversely, even relatively higher whole-body or head-only
exposures to X rays or gamma rays have been inconsistent
in eliciting CNS responses (26–28). To determine whether 2
Gy whole-body gamma-ray irradiation might also trigger
long-term anxiety- and depression-like behavior, male and
female mice were administered the elevated plus maze,
light-dark box and forced swim tests at 6–7 months
postirradiation (EPM, LDB and FST, respectively; Fig. 1).
The EPM and LDB tests are based on the tendency of
anxious rodents to avoid open or brightly-lit areas and to
exhibit reluctance to explore those open environments.
These tendencies result in reduced amounts of time spent in
the open arms of the EPM or in reduced numbers of
transitions between the dark and light compartments of the
LDB testing arena (19). Similarly, the FST provides a
measure of despair- or depression-like behavior where the
animal stops trying to escape the aversive environment of
the water-filled beaker and spends an increased percentage
of the test time immobile. While EPM and LDB testing
showed no effect of irradiation for the male mice, the
irradiated female mice exhibited significantly increased
anxiety-like behavior on both tests (P , 0.05; Fig. 1A and
B). Conversely, no differences between irradiated and
control mice of either sex were observed on the FST where
the analysis of time spent floating is an indicator of
depression-like behavior (Fig. 1C). These data demonstrate
that female mice may be at greater risk for exhibiting
anxiety-like behavior at delayed times after exposure to a
military relevant 2 Gy dose of gamma rays.
Fear extinction memory refers to an active process of
dissociating a learned response to a prior adverse event that
facilitates coping in unpleasant or stressful situations.
During the day-1 conditioning phase of FE, control and
irradiated mice were administered three tone-shock pairings.
All groups of mice showed comparable learning as
demonstrated by similar amounts of time spent freezing
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during this tone-shock conditioning phase (Fig. 2A and C;
T1–T3). Subsequently, the mice exhibited a gradual decrease
in freezing behavior over the three extinction training days
(15 tones/day, data shown as average of 5 tones). However,
both male and female mice that had been irradiated
maintained relatively higher freezing levels on extinction
training days 2 and 3 compared to their respective
nonirradiated controls (P , 0.05). At 24 h after completion
of extinction training, the male and female mice underwent
extinction testing (three tones only, spaced by 120 s). Male
mice that had been irradiated months earlier exhibited
abolished fear memory as demonstrated by freezing
behavior that was indistinguishable from that of the control
males (Fig. 2B). The irradiated female mice, however,
demonstrated an inability to abolish fear memories during
this retrieval testing and exhibited increased freezing again
(P , 0.05; Fig. 2D). This freezing behavior during the
extinction test is reflective of elevated anxiety or an almost
post-traumatic stress disorder (PTSD)-like behavior.
Together, these behavioral testing data indicate alterations
in learning, anxiety and the ability to extinguish fear
memories in the female mice at delayed times postirradi-
ation that are reflective of PTSD-like symptoms. Outcomes
such as these would clearly be detrimental to military
personnel, first responders and civilians with regards to on-
the-job performance and in the long term with regards to
quality of life. However, cohort-averaged data do not
indicate how frequently or dramatically cognitive perfor-
mance is affected in a given population. Therefore, the
individual mouse behavior data were also analyzed using
kernel density estimation (KDE) to generate a performance
probability profile that was then used to determine the
percentage of irradiated mice that exhibited significantly
altered behavior, defined as performance in a task 5th
percentile of the performance observed for the control mice
(22). Analyses of EPM, LDB and FST data by KDE did not
show significant changes. Strikingly however, KDE dem-
onstrated that 33.6% of irradiated female mice were
impaired on the FE test relative to the 5% impairment
threshold applied to control mice (P , 0.05, Fisher’s exact
test; Fig. 2D) and the 8.9% impairment exhibited by
irradiated male mice (Fig. 2B). These data suggest an
absolute relative risk for the irradiated females of 28.6%
compared to 3.9% for the irradiated male mice. The
numbers-needed-to-harm (NNH) algorithm was then ap-
plied to the KDE data (22) and predicted that one in every
four irradiated females would exhibit difficulties with this
FIG. 1. Whole-body exposure to 2 Gy 137Cs gamma rays elicits
anxiety-like behavior in female mice 6–7 months postirradiation.
Increased anxiety-like behavior was observed in irradiated female
mice, but not male mice, as demonstrated by (panel A) reduced time
 
spent in the open arms of the EPM and (panel B) reduced numbers of
transitions between the light and dark chambers in the LDB test. Panel
C: Neither male nor female irradiated mice showed depression-like
behavior on the FST. Data are presented as mean 6 SEM (N ¼ 12
mice/group for male and female controls and for the irradiated female
mice; N ¼ 14 mice/group for the irradiated male mice). Unpaired
Student’s t test, *P , 0.05.
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PTSD-like behavior compared to one in every 26 irradiated
males.
Post-synaptic density protein 95 (PSD-95) is an excitato-
ry-associated synaptic protein involved in plasticity, the
level of which can be influenced by radiation exposure (29,
30). Because PSD-95 is responsible for recruiting receptors
and other proteins to the synaptic cleft, changes in
expression level of PSD-95 may disrupt neurotransmission
in a manner that could contribute to cognitive dysfunction.
After completion of behavior testing, PSD-95 protein levels
were analyzed in the DG region of the hippocampus and in
the amygdala. These analyses showed that whole-body, 2
Gy c irradiation induced decreased protein levels in the DG
at 7–8 months postirradiation in both irradiated male mice
(Fig. 3A–C; P , 0.05) and irradiated female mice (Fig. 3A,
D and E; P, 0.01). Conversely, whole-body, 2 Gy gamma-
ray irradiation induced significantly increased protein levels
in the amygdala at 7–8 months postirradiation in irradiated
male mice (Fig. 3F–H; P , 0.001) and irradiated female
mice (Fig. 3F, I and J; P , 0.01). The functional relevance
of altered PSD-95 protein levels in the irradiated brain has
not been determined, but it may suggest a possible loss of
synaptic integrity. Given that the learning and memory
necessary for fear conditioning and extinction rely upon
functional neural circuitry between the hippocampus and
amygdala (as well as the medial prefrontal cortex) (31), the
observed dysregulation of PSD-95 in both of these regions
of the brain may contribute to the impairments observed on
fear extinction testing in this study (Fig. 2). Barring direct
evidence for that, changes in PSD-95 protein levels appear
to provide a biomarker for irradiation even at very late
postirradiation times.
Microglial activation has been used as a marker for
neuroinflammation in multiple irradiation scenarios, and
that neuroinflammation is thought to contribute to radiation-
induced cognitive dysfunction. Using CD68 as a marker of
microglial activation, a modest, but statistically significant
increase in CD68 protein level was observed in the DG
region of the irradiated hippocampus of male mice at 7–8
months postirradiation (Fig. 4A–C; P , 0.01), which was
not observed in the DG of irradiated female mice (Fig. 4A,
D and E). Similar analysis of the amygdala indicated no
increase in CD68 immunoreactivity in the irradiated male
mice compared to controls (Fig. 4F–H), but a significant
increase in CD68 immunoreactivity was observed in the
amygdala of irradiated female mice (Fig. 4F, I and J; P ,
0.05). These findings reinforce the general supposition that
elevated inflammation contributes to radiation-induce
FIG. 2. Whole-body irradiation compromised fear extinction memory and enhanced memory recall in female
mice. All mice showed elevated freezing after a series of three tone-shock pairings (0.6 mA, T1–T3).
Subsequently, fear extinction training was administered every 24 h (15 tones) for 3 days. These data are
presented as the average of five tones (panels A and C). Both male and female mice showed a gradual decrease
in freezing behavior (days 1–3); however, irradiated mice spent significantly more time freezing compared to
controls on extinction training days 2 and 3. At 24 h after extinction training male mice (panel B) exhibited
successful extinction on the fear test, while irradiated female mice (panel D) exhibited enhanced fear recall. Data
are presented as mean 6 SEM (N¼ 8–12 mice/group). Unpaired Student’s t test, *P , 0.05.
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cognitive impairments (32, 33). More specifically, the
elevated levels of activated microglia in the female
amygdala suggest that persistent neuroinflammation may
have played a disruptive role in fear memory consolidation
in the irradiated female mice as reflected by their increased
freezing during the fear extinction trial (Fig. 2D).
Previously published work performed by others and by us
has suggested that radiation affects changes in DNA
methylation profiles that correlate with cognitive impair-
ments (34–36). In some cases, these changes have been
implicated not just as biomarkers of exposure, but also as a
functionally relevant epigenetic mechanism underlying the
CNS effects of irradiation. Based on these observations,
global levels of both 5-methylcytocine (5mC) and 5-
hydroxymethylcytosine (5hmC) were evaluated in the
hippocampus of the irradiated mice (Fig. 5). Analysis of
5mC, typically a gene silencing epigenetic modification,
showed significantly increased levels in the DG and CA1
FIG. 3. Whole-body 137Cs gamma-ray irradiation (2 Gy) significantly altered the number of PSD-95 puncta. Panel A: Quantification of PSD-95
from deconvoluted confocal images demonstrated significant reductions in the number of PSD-95 puncta in the hippocampus of the irradiated
mouse brain for both male and female mice. Panels B–E: Representative high-resolution confocal micrographs of PSD-95 immunohistochemical
staining in the dentate gyrus (DG) molecular layer of control and irradiated male mice (panels B and C) and female mice (panels D and E) (red,
PSD-95; blue, DAPI nuclear counterstain). Panel F: Conversely, quantification of PSD-95 in the amygdala demonstrated significant increases in
the number of PSD-95 puncta for both male and female irradiated mice. Representative high-resolution confocal micrographs of PSD-95
immunohistochemical staining in the basal lateral amygdala (BLA) of control and irradiated male mice (panels G and H) and female mice (panels I
and J). All data are presented as mean 6 SEM (N¼ 3–4 mice/group). Unpaired Student’s t tests, *P , 0.05, **P , 0.01, **P , 0.001. Scale bar
¼ 20 lm.
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regions of the brain for both male and female irradiated
mice relative to their concurrent controls (Fig. 5A and B; P
, 0.05 and P , 0.01 for males and females, respectively).
Evaluation of 5hmC, thought to be a gene activating
epigenetic modification, was also elevated in the DG region
of the hippocampus of the irradiated male mice (Fig. 5C and
D; P , 0.05) that was not observed in the CA1 region of
those same mice. No increases above control levels of
5hmC were observed in either region of the brain for the
irradiated female mice. Together, these data suggest the
possibility that a whole-body exposure to 137Cs gamma rays
induces epigenetic dysregulation, observed 7–8 months
later, which may cause adverse changes in gene expression
that contribute to cognitive dysfunction.
DISCUSSION
While whole-body exposure to low dose, low-LET
radiation has been shown to induce cognitive dysfunction,
there remains little information to allow for accurate risk
assessment. The numerous exposure scenarios include those
involving military personnel, first responders, cleanup
workers and civilians in the context of a large-scale
accidental or terrorist-mediated release, in addition to other
occupational exposures. Manifestation of impairments such
as mood disorders, learning and memory impairments or
progressive neurodegenerative-like changes can adversely
affect long-term quality of life. In contrast to what has been
demonstrated after clinical exposures, occupational and/or
FIG. 4. Effect of 2 Gy whole-body irradiation on microglial activation. Representative (panel A)
quantification of CD68 immunohistochemical staining of the DG region of the hippocampus demonstrated that
compared to controls, irradiated male mice had increased microglial activation 7–8 months, but that females did
not. Panels B–E: Representative high-resolution confocal micrographs of CD68 immunohistochemical staining
in the dentate hilus (DH) and granular cell layer (GCL) of control and irradiated male mice (panels B and C) and
female mice (panels D and E) (red, CD68; blue, DAPI nuclear counterstain). Panel F: Conversely, quantification
of CD68 in the amygdala region of the brain demonstrated significant increases in the number of activated
microglia in irradiated female mice that were not observed in the irradiated male mice. Representative high-
resolution confocal micrographs from the basal lateral amygdala (BLA) of control and irradiated (panels G and
H) male mice and (panels I and J) female mice. Data are presented as mean 6 SEM (N ¼ 3–4 mice/group).
Unpaired Student’s t test, *P , 0.05, **P , 0.01. Scale bar ¼ 20 lm.
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accidental exposure scenarios are projected to elicit more
subtle cognitive changes that manifest over protracted
postirradiation intervals, if not a lifetime. These factors
have confounded rigorous risk assessments in humans.
The human data regarding CNS risk after radiation
exposure are somewhat conflicting. In published studies of
Chernobyl cleanup workers receiving occupational radiation
exposures, cognitive impairments, as well as other adverse
health outcomes have been reported (37, 38). Those
findings have been supported by three published studies
of female nuclear workers, which suggested that occupa-
tional radiation exposure was linked to increased risk of
mortality from dementia (39–41). Conversely, in a pub-
lished study of more than 2,000 atomic bomb survivors
there was no link found between radiation exposure and
dementia irrespective of dose (42). While prenatal expo-
sures have defined risks for microcephaly and mental
retardation (43), CNS risks are more difficult to define after
exposures to adult populations, prompting further work in
non-human primates (NHP) and other mammalian species.
Non-human primate models provide distinct advantages
for radiation-induced cognitive studies due to their close
match to human behavioral traits and complexity, but such
studies routinely suffer from smaller sample sizes. Rhesus
macaques that received clinically relevant whole-brain
fractionated doses of 8 3 5 Gy (40 Gy), exhibited
significant neuropathology and cognitive decline 14
months later (44). Rhesus macaques that received whole-
body gamma-ray irradiation at a lower dose of 6.75–8.05
Gy were evaluated 3.1–4.3 years later. Those irradiated
animals were less likely to engage in behavior testing,
suggested to be a result of attention deficits. Otherwise, the
irradiated NHP were slower to learn and complete the task,
and had reduced cognitive flexibility (45). Furthermore,
these animals exhibited evidence of persistent inflamma-
tion, expression of complement proteins and T-cell
activation, as well as impaired glutamatergic neurotrans-
mission and signal transduction within the white matter of
the brain (46). While additional evidence in NHP has
pointed to the promise of using circulating biomarkers for
radiation exposures and lethality, they have not been
linked to neurobehavioral outcomes (47–49). As a result,
much of what is known and can be projected regarding
risks to the CNS after whole- or partial-body irradiation
comes from the rodent literature.
FIG. 5. Exposure to 2 Gy of 137Cs c rays results in altered global
DNA methylation in the hippocampus. Representative images show
 
that radiation exposure increased levels of 5mC (panel A) and 5hmC
(panel C) in the DG region of the hippocampus (pyr, pyramidal cell
layer; sr stratum radiatum). Panel B: Quantification of immunohisto-
chemical staining demonstrates that compared to controls, irradiated
male and female mice have increased 5mC in the DG and CA1 regions
of the hippocampus and that (panel D) irradiated male mice have
increased 5hmC in the DG region of the hippocampus (red; 5mC,
5hmC). Data are presented as mean 6 SEM (N ¼ 3–4 mice/group).
Unpaired Student’s t test, *P , 0.05, **P , 0.01. Scale bar¼ 40 lm.
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As described by others, even relatively higher whole-
body doses of low-LET radiation have been inconsistent in
eliciting CNS responses in rodent studies (50–52). This
lack of consistency may be attributed to differences in
exposure paradigms, postirradiation analysis times and the
types of behavioral testing paradigms used. Head-only
irradiations using 2 Gy of either X rays or gamma rays
were demonstrated to induce behavioral decrements and
decreased neurogenesis in two published rodent studies
(26, 53, 54). A comparison of rats exposed to either 4He or
gamma rays demonstrated consistent decrements after 4He
irradiation that did not manifest after gamma-ray irradia-
tion, where 50–200 cGy doses of gamma rays elicited
anxiety-like behavior on the EPM, but no decrements on
the novel object and novel place recognition tests that
measure perirhinal cortex- and hippocampal-dependent
learning and memory, respectively (50). While certain
findings point to the ability of lower, whole-body low-LET
radiation exposures to elicit functional CNS decrements,
the data remain inconclusive in that definitive dose
thresholds and time to onset for neurocognitive deficits
has remained difficult to elucidate.
The scarcity of carefully controlled neurocognitive studies
after low-dose, whole-body irradiation prompted the current
study where it was anticipated that lower dose exposures
would require longer times for behavioral decrements to
manifest. For that reason, male and female mice were used
in the current study to evaluate the brain for the delayed
CNS effects beginning 6–7 months after whole-body low-
dose gamma irradiation, which would not induce acute
radiation sickness. Behavioral testing indicated sex-specific
differences in the induction of anxiety-like behaviors, in
which females were much more sensitive than males. It was
noted that for the first behavior test, EPM, control male
mice spent significantly less time in the open arms of the
maze than did the females. This discrepancy was not
evident in subsequent behavior tests, suggesting that more
pre-test handling might have been needed for the male mice
than the females in this particular study.
The fact that male mice exhibited relatively normal
cognitive function while exhibiting similar or worse
molecular pathology compared to the females was some-
what surprising. However, it is challenging to correlate this
behavioral testing data with tangible estimates of radiation-
induced CNS impairments, particularly given the lack of
epidemiological data. KDE provides a means to define a
level of behavioral performance that might represent
significant cognitive deficits and to estimate the number
of severely affected individuals within a study cohort (22).
In this case, the control cohort was assigned a 5% level of
performance, below which the irradiated animals were
considered severely impaired. By entering the numbers
derived from KDE into the NNH algorithm, an estimate of
absolute relative risk and of the potential frequency of
impaired behavior outcomes for the FE test was obtained
(Fig. 2A and D). Dramatically, this analysis predicted that at
least 1 in 4 women would exhibit anxiety- or PTSD-like
impairments at delayed times after a 2 Gy whole-body
exposure, while such symptoms would manifest in only 1 in
26 men.
While cognitive impairments were not significantly
evident in the male mice, molecular analyses showed
alterations in post-synaptic protein levels in both male and
female mice that might affect synaptic plasticity, and
showed increased indications of neuroinflammation in male
mice as measured by CD68þ microglia staining. Significant
alterations in global levels of DNA methylation were also
observed in the hippocampus of both the male and female
irradiated mice. Altogether, these data suggest several
conclusions. The first is that more sensitive and/or rigorous
behavioral testing might be required to uncover more subtle
effects in animals exposed to whole-body, low-LET
radiation. The data also suggest that 2 Gy may be near
the dose threshold for eliciting radiation-induced behavioral
impairments in this paradigm. Furthermore, estrus cycle is a
factor that could contribute to the observed sex-specific
differences in the CNS radiation response and cognitive
dysfunction, although studies of high-LET radiation
exposures have suggested the possibility that females might
be more resistant to radiation-induced cognitive impair-
ments (4, 55). However, systematic studies need to be
conducted to critically evaluate the link between radiation-
induced CNS effects and hormone cycles. Finally, the
observed epigenetic changes have been posited to be a
potential epigenetic mechanism that ultimately contributes
to radiation-induced cognitive dysfunction (34–36). If a
causative link could be established between alterations in
DNA methylation and cognitive changes, it may provide a
logical avenue for the development of radiation protection
and mitigation strategies.
Due to global tensions and proliferation of nuclear arms,
as well as accidents such as Chernobyl and Fukushima, the
evaluation of radiation-induced cognitive impairments will
remain a priority. A better understanding the CNS response
to such radiation exposure scenarios will improve risk
assessment and provide guidance in the development of
effective radiation countermeasures to protect military
personnel and civilians alike.
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